Recent News

• 04.17.2025 - Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease
• 04.17.2025 - Alector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer’s Disease
• 03.28.2025 - Alector Provides Executive Leadership Update
• 03.28.2025 - Alector Provides Executive Leadership Update
• 03.28.2025 - Alector Provides Executive Leadership Update
• 03.18.2025 - Stifel 2025 Virtual CNS Forum
• 03.18.2025 - Stifel 2025 Virtual CNS Forum
• 03.11.2025 - Sean Laaman
• 03.11.2025 - Sean Laaman
• 03.11.2025 - Leerink Partners Global Biopharma Conference

Recent Filings

• 03.28.2025 - 8-K Current report
• 03.10.2025 - 8-K Current report
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.28.2025 - 144 Report of proposed sale of securities